Intrepid Potash (NYSE:IPI – Get Free Report) is one of 295 public companies in the “Chemicals” industry, but how does it weigh in compared to its peers? We will compare Intrepid Potash to similar companies based on the strength of its analyst recommendations, risk, valuation, earnings, institutional ownership, profitability and dividends.
Risk and Volatility
Intrepid Potash has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. Comparatively, Intrepid Potash’s peers have a beta of 0.92, suggesting that their average share price is 8% less volatile than the S&P 500.
Insider & Institutional Ownership
56.1% of Intrepid Potash shares are held by institutional investors. Comparatively, 47.4% of shares of all “Chemicals” companies are held by institutional investors. 2.3% of Intrepid Potash shares are held by company insiders. Comparatively, 13.7% of shares of all “Chemicals” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Intrepid Potash and its peers top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Intrepid Potash | $298.33 million | $11.19 million | 17.96 |
| Intrepid Potash Competitors | $6.35 billion | $222.31 million | -0.87 |
Intrepid Potash’s peers have higher revenue and earnings than Intrepid Potash. Intrepid Potash is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Intrepid Potash and its peers, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Intrepid Potash | 1 | 1 | 2 | 1 | 2.60 |
| Intrepid Potash Competitors | 3248 | 12209 | 14130 | 519 | 2.40 |
Intrepid Potash currently has a consensus target price of $36.67, indicating a potential upside of 11.59%. As a group, “Chemicals” companies have a potential upside of 8.89%. Given Intrepid Potash’s stronger consensus rating and higher possible upside, equities analysts plainly believe Intrepid Potash is more favorable than its peers.
Profitability
This table compares Intrepid Potash and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Intrepid Potash | 8.94% | 4.74% | 3.73% |
| Intrepid Potash Competitors | -61.35% | 1.23% | -1.42% |
Summary
Intrepid Potash beats its peers on 9 of the 13 factors compared.
Intrepid Potash Company Profile
Intrepid Potash, Inc., together with its subsidiaries, engages in the extraction and production of the potash in the United States and internationally. It operates through three segments: Potash, Trio, and Oilfield Solutions. The company offers muriate of potash for various markets, such as agricultural market as a fertilizer input; the industrial market as a component in drilling and fracturing fluids for oil and gas wells, as well as an input to other industrial processes; and the animal feed market as a nutrient supplement. It also provides Trio, a specialty fertilizer that delivers potassium, sulfate, and magnesium in a single particle; water for oil and gas services industry; salt for various markets, including animal feed, industrial applications, pool salt, and the treatment of roads and walkways for ice melting or to manage road conditions; magnesium chloride for use as a road treatment agent for deicing and dedusting; brines for use in oil and gas industry to support well workover and completion activities; and metal recovery salts. Intrepid Potash, Inc. was founded in 1999 and is based in Denver, Colorado.
Receive News & Ratings for Intrepid Potash Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrepid Potash and related companies with MarketBeat.com's FREE daily email newsletter.
